Windlas Biotech IPO Today: GMP, Subscription Status, Key Details. Should you Invest?

Analysts noted that the company has had a strong financial track record and predict a positive outlook for Windlas Biotech in the long-term.

Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.